Atlas Trials

Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas

Clinical trial NCT04772456 · RECRUITING

Trial details

NCT number
NCT04772456
Sponsor
University of Maryland, Baltimore
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Glioma
Start date
2020-08-11
Primary completion
2026-08-31
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.